A new research document with title ‘Alopecia – Pipeline Review, H2 2017’ covering detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis and important players/vendors such as RXi Pharmaceuticals Corp, Samumed LLC, Switch Biotech LLC etc. The report will help user gain market insights, future trends and growth prospects for forecast.
Request a sample report @ https://www.htfmarketreport.com/sample-report/575232-alopecia-pipeline-review-1
Alopecia – Pipeline Review, H2 2017
The latest Pharmaceutical and Healthcare disease pipeline guide Alopecia – Pipeline Review, H2 2017, provides an overview of the Alopecia (Dermatology) pipeline landscape.
Alopecia is the partial or complete loss of hair especially on the scalp either in patches, on the entire head or over the entire body. Thinning hair is the most obvious symptom. The predisposing factors include allergies, irritants, toxins, burns, injuries, and infections.
The Pharmaceutical and Healthcare latest pipeline guide Alopecia – Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Alopecia (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 1, 12, 5, 1, 19 and 9 respectively. Similarly, the Universities portfolio in Phase III and Discovery stages comprises 1 and 1 molecules, respectively.
Alopecia (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from The proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
– The pipeline guide provides a snapshot of the global therapeutic landscape of Alopecia (Dermatology).
– The pipeline guide reviews pipeline therapeutics for Alopecia (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Alopecia (Dermatology) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Alopecia (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Alopecia (Dermatology)
Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=575232
Reasons to buy
– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Alopecia (Dermatology).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Alopecia (Dermatology) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Companies Mentioned in the Report
Aclaris Therapeutics Inc
Brickell Biotech Inc
Bristol-Myers Squibb Company
Daewoong Pharmaceutical Co Ltd
Dong-A Socio Holdings Co Ltd
Hyundai Pharmaceutical Co Ltd
Kuhnil Pharmaceutical Co Ltd
Lee’s Pharmaceutical Holdings Ltd
LEO Pharma A/S
NovaLead Pharma Pvt Ltd
Panacea Biotec Ltd
Quark Pharmaceuticals Inc
RXi Pharmaceuticals Corp
Switch Biotech LLC
Taisho Pharmaceutical Holdings Co Ltd
viDA Therapeutics Inc
Get customization & check discount for report @ https://www.htfmarketreport.com/request-discount/575232-alopecia-pipeline-review-1
Table of Contents
List of Tables 4
List of Figures 5
Global Markets Direct Report Coverage 6
Alopecia – Overview 7
Alopecia – Therapeutics Development 8
Pipeline Overview 8
Pipeline by Companies 9
Pipeline by Universities/Institutes 12
Products under Development by Companies 13
Products under Development by Universities/Institutes 16
Alopecia – Therapeutics Assessment 17
Assessment by Target 17
Assessment by Mechanism of Action 20
Assessment by Route of Administration 23
Assessment by Molecule Type 25
Alopecia – Companies Involved in Therapeutics Development 27
Aclaris Therapeutics Inc 27
Allergan Plc 27
Almirall SA 28
AndroScience Corp 28
Berg LLC 29
BiologicsMD Inc 29
BirchBioMed Inc 30
Brickell Biotech Inc 30
Bristol-Myers Squibb Company 31
Cassiopea SpA 31
Daewoong Pharmaceutical Co Ltd 32
Dong-A Socio Holdings Co Ltd 32
Handok Inc 33
Histogen Inc 33
Hyundai Pharmaceutical Co Ltd 34
Incyte Corp 34
Kuhnil Pharmaceutical Co Ltd 35
Lee’s Pharmaceutical Holdings Ltd 35
LEO Pharma A/S 36
Medivir AB 36
NovaLead Pharma Pvt Ltd 37
Panacea Biotec Ltd 37
Pfizer Inc 38
Quark Pharmaceuticals Inc 38
RXi Pharmaceuticals Corp 39
Samumed LLC 39
Switch Biotech LLC 40
View Detailed Table of Content @ https://www.htfmarketreport.com/reports/575232-alopecia-pipeline-review-1
Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
CRAIG FRANCIS (PR & Marketing Manager)
Ph: +1 (206) 317 1218